Skip to content
ArgusEye

ArgusEye

  • About Us
  • Applications
  • Technology
  • News
  • Team
  • Contact us
April 11, 2022April 11, 2022News

Another successful week for ArgusEye during TESTA Challenge 2022

During March 14 – April 1, ArgusEye participated in the second edition of TESTA Challenge in Uppsala. This event is organized by TESTA Center in […]

February 25, 2022February 25, 2022News

ArgusEye selected for TESTA Challenge 2022

ArgusEye has again been selected to participate in TESTA Challenge hosted by TESTA Center in Uppsala, Sweden. This is the second edition of TESTA Challenge […]

December 6, 2021December 6, 2021News

ArgusEye completes oversubscribed seed funding round

ArgusEye has successfully completed its first external financing round, securing additional funding for further product development and team expansion. The strong investor syndicate in this […]

November 2, 2020November 2, 2020News

A successful week for ArgusEye during TESTA Challenge 2020

During October 19-23, ArgusEye participated in TESTA Challenge in Uppsala. This is a new initiative organized by TESTA Center, STUNS and Cytiva. The objective is […]

September 7, 2020November 2, 2020News

ArgusEye selected for TESTA Challenge 2020

ArgusEye has been selected to participate in TESTA Challenge 2020 hosted by TESTA Center in Uppsala, Sweden TESTA Challenge is a new initiative organized by […]

August 27, 2019November 2, 2020News

ArgusEye at NLS Days 2019, September 10-12

ArgusEye’s CEO Dr. Erik Martinsson will participate at the Nordic Life Science Days 2019 Nordic Life Science Days 2019 will take place on September 10-12 […]

November 14, 2018November 15, 2018News

ArgusEye receives new grant from Vinnova

In tough competition with other innovative start-up companies, ArgusEye is granted 900 000 SEK from Vinnova’s program Innovative Startups Step 2. In September 2017, ArgusEye received […]

May 14, 2018May 14, 2018News

ArgusEye is granted 500 000 SEK from Vinnova

ArgusEye AB is granted 500 000 SEK from Vinnova’s Runner Up program for the project ”ArgusEye – driving the revolution in manufacturing of biopharmaceuticals”. ArgusEye obtained […]

Welcome to ArgusEye!

ArgusEye AB is a newly established biotech company from Sweden. We develop biosensor systems for your specific application and need.

Our technology is based on extensive academic research conducted at Linköping University and

uses nanoplasmonic sensing in combination with fiber optics. By adding customized ligands we

can provide sensitive and miniturized sensing system for your target of interest.

Copyright ArgusEye AB 2022

© 2022 ArgusEye. Proudly powered by Sydney